Abstract
Marijuana (Cannabis sativa) is the illicit drug most commonly used by two vulnerable populations relevant to neurodevelopment—pregnant women and teenagers. Human longitudinal studies have linked prenatal and adolescent cannabis exposure with long-term behavioral abnormalities as well as increased vulnerability to neuropsychiatric disorders in adulthood. Animal models provide a means of studying the neurobiological mechanisms underlying these long-term effects. This chapter provides an overview of the animal models we have used to study the developmental impact of cannabis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
SAMHSA, Results from the 2006 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration 2007, Rockville, MD: Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293
Lozano, J., et al. (2007) Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr. 96, 1734–7
El Marroun, H., et al. (2008) Demographic, emotional and social determinants of cannabis use in early pregnancy: The Generation R study. Drug Alcohol Depend. 98, 218–26
Fergusson, D.M., L.J. Horwood, and K. Northstone (2002) Maternal use of cannabis and pregnancy outcome. Bjog. 109, 21–7
Williamson, S., et al. (2006) Determination of the prevalence of drug misuse by meconium analysis. Arch Dis Child Fetal Neonatal Ed. 91, F291–2
Pertwee, R.G. (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153, 199–215
Hurd, Y.L., et al. (2005) Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol. 27, 221–9
Day, N.L., et al. (1994) Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin Exp Res. 18, 786–94
Fried, P.A. (1995) Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis. Arch Toxicol Suppl. 17, 233–60
Fried, P.A. and B. Watkinson (2001) Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 23, 421–30
Arseneault, L., et al. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Bmj. 325, 1212–3
Patton, G.C., et al. (2002) Cannabis use and mental health in young people: cohort study. Bmj. 325, 1195–8
Richardson, G.A., N.L. Day, and L. Goldschmidt (1995) Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development. Neurotoxicol Teratol. 17, 479–87
Huizink, A.C. and E.J. Mulder (2006) Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev. 30, 24–41
Kandel, D.B. (2003) Does marijuana use cause the use of other drugs? Jama. 289, 482–3
Porath, A.J. and P.A. Fried (2005) Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol. 27, 267–77. Epub 2005 Jan 8
Rice, D. and S. Barone, Jr. (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 108 Suppl 3, 511–33
Charmandari, E., et al. (2003) Pediatric stress: hormonal mediators and human development. Horm Res. 59, 161–79
Arseneault, L., et al. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Bmj. 325, 1212–3
Fergusson, D.M., L.J. Horwood, and N.R. Swain-Campbell (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med. 33, 15–21
van Os, J., et al. (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 156, 319–27
Green, A.I., et al. (2004) First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res. 66, 125–35
Veen, N.D., et al. (2004) Cannabis use and age at onset of schizophrenia. Am J Psychiatry. 161, 501–6
Lynskey, M.T., et al. (2003) Escalation of drug use in early-onset cannabis users vs co-twin controls. J.A.M.A. 289, 427–433
Fergusson, D.M. and L.J. Horwood (2000) Does cannabis use encourage other forms of illicit drug use? Addiction. 95, 505–520
Agrawal, A., et al. (2004) A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med. 34, 1227–37
Clancy, B., et al. (2007) Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics. 5, 79–94
Muhuri, P.K. and J.C. Gfroerer (2009) Substance use among women: associations with pregnancy, parenting, and race/ethnicity. Matern Child Health J. 13, 376–85
Izzo, A.A., et al. (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences. 30, 515–27
Mechoulam, R. and L. Hanus (2000) A historical overview of chemical research on cannabinoids. Chem Phys Lipids. 108, 1–13
Mechoulam, R., et al. (2007) Cannabidiol – recent advances. Chemistry & biodiversity. 4, 1678–92
Pertwee, R.G. (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology. 153, 199–215
Turner, C.E., M.A. Elsohly, and E.G. Boeren (1980) Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 43, 169–234
Ren, Y., et al. (2009) Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 29, 14764–9
Garcia-Gil, L., et al. (1999) Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol. Drug Alcohol Depend. 55, 127–36
Navarro, M., et al. (1994) Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol Biochem Behav. 47, 47–58
Perez-Rosado, A., et al. (2002) Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Delta(9)-tetrahydrocannabinol. Neurotox Res. 4, 211–8
Rodriguez de Fonseca, F., et al. (1991) Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43, 713–23
Spano, M.S., et al. (2007) Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry. 61, 554–63
Vela, G., et al. (1998) Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain research. 807, 101–9
Walters, D.E. and L.A. Carr (1986) Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol Biochem Behav. 25, 763–8
Walters, D.E. and L.A. Carr (1988) Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol Biochem Behav. 29, 213–6
Galler, J.R. and G. Turkewitz (1975) Variability of the effects of rearing in a large litter on the development of the rat. Dev Psychobiol. 8, 325–31
Heggeness, F.W., et al. (1961) Weight gains of overnourished and undernourished preweanling rats. J Nutr. 75, 39–44
Kumaresan, P., R.R. Anderson, and C.W. Turner (1966) Effect of litter size upon milk yield and litter weight gains in rats. Rev Tuberc Pneumol (Paris). 30, 41–5
Widdowson, E.M. and C.R. Mc (1960) Some effects of accelerating growth. I. General somatic development. Proc R Soc Lond B Biol Sci. 152, 188–206
Jen, K.C., F. Wehmer, and J. Morofski (1978) Effects of undernutrition and litter size on material variables and pup development. Dev Psychobiol. 11, 279–87
Nagy, Z.M., K.J. Porada, and J.A. Anderson (1977) Undernutrition by rearing in large litters delays the development of reflexive, locomotor, and memory processes in mice. J Comp Physiol Psychol. 91, 682–96
Alleva, E., A. Caprioli, and G. Laviola (1989) Litter gender composition affects maternal behavior of the primiparous mouse dam (Mus musculus). J Comp Psychol. 103, 83–7
Spear, L.P. (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 24, 417–63
Andersen, S.L. (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev. 27, 3–18
Ellgren, M., et al. (2008) Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol. 18, 826–34
Ellgren, M., S.M. Spano, and Y.L. Hurd (2007) Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 32, 607–15
Wang, X., et al. (2006) Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J. 6, 255–64
Zuckerman, B., et al. (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 320, 762–8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
DiNieri, J.A., Hurd, Y.L. (2012). Rat Models of Prenatal and Adolescent Cannabis Exposure. In: Kobeissy, F. (eds) Psychiatric Disorders. Methods in Molecular Biology, vol 829. Humana Press. https://doi.org/10.1007/978-1-61779-458-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-61779-458-2_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-457-5
Online ISBN: 978-1-61779-458-2
eBook Packages: Springer Protocols